Clinical Trial

Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI )

Study acronym: KETZEREI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 27, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Acute kidney injury (AKI) is a well-recognized complication in critically ill patients, which often leads to the necessity of mechanical kidney support (CRRT). In current therapeutic regimes, CRRT is used to strictly prevent azotaemia. Thus recent clinical observations, as well as data from animal testing suggest a link between controlled azotaemia and faster renal recovery in AKI patients. The aim of the study is to improve renal recovery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-08-31; most recent amendment 2024-11-25.
Status change: Not Yet Recruiting → Recruiting 2024-02-19
Trial Details
NCT Number NCT06021288
Lead Sponsor Universität Münster
Conditions Critical Illness, Acute Kidney Injury
Enrollment 165 participants
Start Date 2023-10-02
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-27